H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells
Science Advances · 2025
DOI: 10.1126/sciadv.adt8765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Emmalee W Cooke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Histones, Pluripotent Stem Cells, Gene Expression Regulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Metazoan nucleosomes harboring H3K79 methylation (H3K79me) deposited by the methyltransferase DOT1L (disruptor of telomeric silencing 1-like) decorate actively transcribed genes. While DOT1L regulates transcription and the pathogenesis of leukemia and neurological disorders, the role of H3K79me remains elusive. Here, we reveal a functional synergism between H3K79me and H3K36 trimethylation (H3K36me3) in regulating gene expression and cellular differentiation. Simultaneous catalytic inactivation of DOT1L and the H3K36 methyltransferase SETD2 (SET domain containing 2) leads to hyperactive transcription and failures in neural differentiation. H3K79me/H3K36me3 loss causes increased transcription elongation, gained chromatin accessibility at a group of enhancers, and increased recruitment of TEAD4 (TEA domain transcription factor 4) and its coactivator YAP1 (Yes-associated protein 1) to these enhancers. Furthermore, YAP-TEAD inhibition restores the expression levels of genes hyperactivated by H3K79me/H3K36me3 loss. Together, we demonstrate a synergism of H3K79me and H3K36me3 in regulating transcription and cell fate transition, unveil the underlying mechanisms, and provide insight into targeting diseases driven by misregulation/mutations of DOT1L and/or SETD2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
- Case Comprehensive Cancer Center, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
- Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai, China.
- Department of Genetics and Genome Sciences, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
ORCID-Profile: Emmalee W Cooke, Cheng Zeng, Suza Mohammad Nur, Yunbo Jia, Jiwei Chen, Peidong Gao, Fei Xavier Chen, Fulai Jin, Kaixiang Cao
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
- NHGRI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Cooke, E. W., Zeng, C., Nur, S. M., Jia, Y., Huang, A., Chen, J., Gao, P., Chen, F. X., Jin, F., & Cao, K. (2025). H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells. Science Advances. https://doi.org/10.1126/sciadv.adt8765
Vancouver
Cooke EW, Zeng C, Nur SM, Jia Y, Huang A, Chen J, et al. H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells. Science Advances. 2025. doi:10.1126/sciadv.adt8765
BibTeX
@article{Cooke2025,
author = {Cooke, Emmalee W and Zeng, Cheng and Nur, Suza Mohammad and Jia, Yunbo and Huang, Aileen and Chen, Jiwei and Gao, Peidong and Chen, Fei Xavier and Jin, Fulai and Cao, Kaixiang},
title = {H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt8765}
}
EUVIMED